Abstract
The hemodynamic effects of physostigmine, a cholinomimetic drug used in the experimental treatment of Alzheimer's disease, are largely unknown. The author describes the development of episodes of hypertension in an elderly patient with Alzheimer's disease following treatment with oral physostigmine.
Original language | English (US) |
---|---|
Pages (from-to) | 910-912 |
Number of pages | 3 |
Journal | American Journal of Psychiatry |
Volume | 143 |
Issue number | 7 |
DOIs | |
State | Published - 1986 |
ASJC Scopus subject areas
- Psychiatry and Mental health